Temperature Management Market Size, Share & Trend Analysis - Global - 2025-2031 - Includes: Surface-Pad Market and Intravascular Market
Description
Global Temperature Management Market Report, 2025 Edition
Executive Summary
The global temperature management market was valued at 325 million dollars in 2024. The market is expected to grow at a 5.4 percent CAGR to reach nearly 471 million dollars by 2031. Temperature management is an essential component of critical care, perioperative care and emergency medicine. It supports controlled regulation of patient temperature during procedures, after cardiac arrest, during trauma care and in complex medical episodes requiring thermal stabilization.
This report covers the global market for surface pad machines and accessories and intravascular machines and accessories. It quantifies units sold, average selling prices, market values, growth rates and competitive shares. It also analyzes growth drivers, market limiters, recent mergers and acquisitions, product portfolios, trends in clinical adoption and developments across major regions.
Clinicians are moving toward less invasive techniques, including surface pad temperature management systems. These systems offer advantages in ease of use, reduced procedural risk and compatibility with modern clinical workflows. As technology continues to evolve and improve, the trend toward less invasive temperature control will strengthen, especially after severe events such as cardiac arrest.
Historical data is included from 2021 to 2024, with forecasts to 2031. The report provides a comprehensive view of the temperature management market and its transition toward improved safety, efficiency and broader application within critical care.
Market Overview
Temperature management devices are used to regulate patient temperature before, during and after medical procedures. Applications include post cardiac arrest care, neuroprotection, perioperative warming and cooling, trauma management, and fever control in intensive care settings.
The market includes two main categories: surface pad temperature management systems and intravascular temperature management systems. Surface pad systems circulate cooled or warmed fluid through pads placed on the patient’s skin. Intravascular systems use catheters inserted into blood vessels to directly regulate core temperature.
In recent years, clinicians have shown a preference for less invasive platforms. Surface pad systems are easier to apply, require less training, and avoid the risks associated with intravascular catheter placement. Improvements across pad materials, ergonomic designs, sensors and user interfaces have made surface systems more effective and more appealing.
Several countries have revised treatment guidelines for post cardiac arrest care and therapeutic hypothermia. These changes influence purchasing behavior as hospitals update their protocols for targeted temperature management (TTM). In some regions, earlier enthusiasm for deep cooling has shifted toward maintaining normothermia. These evolving guidelines create mixed effects on overall demand, depending on how facilities choose to implement temperature management strategies.
Demographic trends also impact the market. As more healthcare systems manage larger volumes of elderly individuals with chronic disease, demand for temperature management during surgeries and emergency events increases. Temperature control improves patient outcomes, reduces complications and supports recovery in high risk populations.
Technological improvements have contributed to market growth. Systems now incorporate automated feedback loops, improved sensors and wireless connectivity. Facilities in both mature and developing regions rely on temperature management devices to meet modern standards of care.
Overall, the market reflects a balance of strong clinical need, advances in non invasive platforms and evolving guidelines that shape long term strategies for post cardiac arrest cooling and perioperative warming.
Market Drivers
Demographic Factors
The global population over age 65 is increasing rapidly, driven by aging baby boomer groups and improved life expectancy. Older adults typically have higher rates of chronic conditions and are more likely to require complex medical interventions. As a result, they represent a growing proportion of patients requiring temperature management during surgery or after emergency events.
Healthcare utilization rises as populations age. More elderly individuals undergo cardiovascular procedures, orthopedic surgeries, neurosurgical procedures and emergency interventions. Temperature management is integrated into many of these care pathways, which increases demand for both surface and intravascular systems.
Interest in patient monitoring and homecare solutions is expanding as well. Patients and caregivers are more aware of the benefits of thermal regulation and how it contributes to safe recovery and improved outcomes. These demographic shifts contribute to the overall growth of the temperature management market.
Cardiovascular Disease Burden
Cardiovascular disease remains the leading cause of death worldwide. In 2021, it accounted for nearly one third of all deaths globally. Patients with CVD often require temperature management during cardiac procedures, after cardiac arrest and in related interventions.
Targeted temperature management is frequently used following out of hospital cardiac arrest. As the prevalence of CVD grows and more patients require emergency intervention, temperature management will continue to play a vital role in stabilizing patients and improving outcomes. This relationship between cardiovascular disease and TTM contributes significantly to market expansion.
Shift Toward Less Invasive Technology
Clinicians are moving toward less invasive platforms for temperature management. Surface pad systems provide effective thermal control without the risks associated with intravascular catheters. These systems require less training, reduce procedure time and are easier to manage in high acuity environments.
Surface pad systems are especially attractive after severe medical events such as cardiac arrest. They avoid complications related to invasive access, reduce infection risk and support broader deployment across facilities.
Advances in pad design, fluid circulation technology and intelligent temperature monitoring have increased the effectiveness of surface systems. As a result, clinicians view non invasive methods as safe and reliable alternatives to invasive techniques.
Market Limiters
Impact of European Guidelines
In 2022, the European Resuscitation Council and the European Society of Intensive Care Medicine revised their guidelines on post cardiac arrest care. New recommendations shifted focus away from therapeutic hypothermia and prioritized maintaining normothermia.
These changes were based on clinical trials that showed limited difference between targeted hypothermia and targeted normothermia in comatose out of hospital cardiac arrest patients. Because Europe represents a significant share of the global temperature management market, this shift has reduced growth potential in regions where cooling had been widely adopted.
As a result, global demand for temperature management devices is more limited than earlier forecasted projections suggested before guideline changes.
Lack of Clinical Data and Market Uncertainty
Targeted temperature management became common practice only in 2002. Since then, studies have raised questions about the benefits of deep cooling. As debate continues about the most effective approach, clinicians face uncertainty about long term best practices.
Some experts propose more high quality randomized trials to clarify the appropriate use of TTM after cardiac arrest. Until more clinical consensus is reached, adoption may be cautious in regions where protocols are being evaluated.
This uncertainty limits the long term growth potential of temperature management devices, especially in regions that follow evidence based guidelines closely.
Shift Toward Consignment Models
Temperature management machines are increasingly placed on consignment rather than purchased outright. Under these models, companies provide machines free of charge on the condition that hospitals purchase consumables such as catheters, pads and blankets on multi year contracts.
Consumables are lucrative for manufacturers and provide predictable revenue. However, because so many machines are installed free of charge, average selling prices for capital equipment are suppressed. This limits total market value even as unit placement grows.
Competition among vendors has intensified this trend. With limited capital purchasing funds available, vendors use consignment to secure long term relationships. While effective commercially, it depresses reported ASPs and restricts overall market growth in capital equipment.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Market forecasts
Growth rates
Units sold
Average selling prices
Qualitative Coverage
Growth trends
Market limiters
Competitive analysis and SWOT
Mergers and acquisitions
Company profiles and product portfolios
FDA recalls
Disruptive technologies
Disease and demographic overviews
Time Frame
Historical data from 2021 to 2024
Base year 2024
Forecasts to 2031
Data Sources
Primary interviews with industry leaders
Government physician and hospital datasets
Regulatory sources
Hospital private data
Import and export records
iData Research internal database
Markets Covered and Segmentation
Global Temperature Management Market Segmentation
Surface Pad Market
Further Segmented Into:
Machines
Accessories
Intravascular Market
Further Segmented Into:
Machines
Accessories
These segments include all capital systems, consumables, and related components used in temperature regulation across hospital departments.
Competitive Analysis
Becton Dickinson (BD)
BD was the leading competitor in the global temperature management market in 2024. Its flagship product line, Arctic Sun, is a non-invasive surface pad temperature management system that regulates patient temperature using circulating chilled water. The Arctic Sun 5000 system is the core of BD’s offering, providing advantages in performance, safety, cost effectiveness and ease of use.
In 2020, BD launched an upgraded technology known as the Arctic Sun Stat. This system offers improved ergonomics for enhanced usability, wireless connectivity for remote monitoring and control, and intelligent temperature fluctuation monitoring. BD also provides ArcticGel pads designed specifically for use with Arctic Sun systems.
ZOLL Medical
ZOLL Medical was the second leading competitor in 2024 due to its exclusive presence in the intravascular temperature management market. ZOLL offers the Thermogard XP system and the Thermogard HQ platform. The company also offers the STx Surface Cooling system, which it acquired from Philips following the acquisition of Philips’ InnerCool temperature management business in 2014.
ZOLL’s strong position in intravascular temperature management allows it to serve high acuity environments where precise control is required.
Gentherm
Gentherm held a notable share of the temperature management market in 2024. The company’s key products include the Blanketrol III hyper hypothermia system and the WarmAir convective warming system. Gentherm also offers accessories and consumables that support ongoing usage across a wide range of clinical settings.
Technology and Practice Trends
Temperature management technology continues to evolve across several dimensions:
Growth in non invasive systems as hospitals prioritize ease of use and reduced procedural risk
Improvements in fluid circulation systems that support faster warming or cooling
Wireless connectivity that allows clinicians to monitor and adjust temperatures remotely
Increased automation through intelligent feedback loops and advanced sensors
Expanded use of disposable pads and catheters to reduce infection risks
Integration of temperature management within perioperative and critical care protocols
These trends support wider adoption and improved clinical workflows.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where is the strongest growth potential within the temperature management market
How will evolving guidelines on therapeutic hypothermia influence purchasing
Which technologies are gaining traction across surface and intravascular platforms
What is the role of consumables in long term revenue generation
How do demographic and cardiovascular trends influence volume demand
Which competitors hold the strongest positions and why
How will consignment models shape future ASP trends
This report provides comprehensive insights for product planning, competitive positioning, commercial strategy and forecasting through 2031.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global temperature management market was valued at 325 million dollars in 2024. The market is expected to grow at a 5.4 percent CAGR to reach nearly 471 million dollars by 2031. Temperature management is an essential component of critical care, perioperative care and emergency medicine. It supports controlled regulation of patient temperature during procedures, after cardiac arrest, during trauma care and in complex medical episodes requiring thermal stabilization.
This report covers the global market for surface pad machines and accessories and intravascular machines and accessories. It quantifies units sold, average selling prices, market values, growth rates and competitive shares. It also analyzes growth drivers, market limiters, recent mergers and acquisitions, product portfolios, trends in clinical adoption and developments across major regions.
Clinicians are moving toward less invasive techniques, including surface pad temperature management systems. These systems offer advantages in ease of use, reduced procedural risk and compatibility with modern clinical workflows. As technology continues to evolve and improve, the trend toward less invasive temperature control will strengthen, especially after severe events such as cardiac arrest.
Historical data is included from 2021 to 2024, with forecasts to 2031. The report provides a comprehensive view of the temperature management market and its transition toward improved safety, efficiency and broader application within critical care.
Market Overview
Temperature management devices are used to regulate patient temperature before, during and after medical procedures. Applications include post cardiac arrest care, neuroprotection, perioperative warming and cooling, trauma management, and fever control in intensive care settings.
The market includes two main categories: surface pad temperature management systems and intravascular temperature management systems. Surface pad systems circulate cooled or warmed fluid through pads placed on the patient’s skin. Intravascular systems use catheters inserted into blood vessels to directly regulate core temperature.
In recent years, clinicians have shown a preference for less invasive platforms. Surface pad systems are easier to apply, require less training, and avoid the risks associated with intravascular catheter placement. Improvements across pad materials, ergonomic designs, sensors and user interfaces have made surface systems more effective and more appealing.
Several countries have revised treatment guidelines for post cardiac arrest care and therapeutic hypothermia. These changes influence purchasing behavior as hospitals update their protocols for targeted temperature management (TTM). In some regions, earlier enthusiasm for deep cooling has shifted toward maintaining normothermia. These evolving guidelines create mixed effects on overall demand, depending on how facilities choose to implement temperature management strategies.
Demographic trends also impact the market. As more healthcare systems manage larger volumes of elderly individuals with chronic disease, demand for temperature management during surgeries and emergency events increases. Temperature control improves patient outcomes, reduces complications and supports recovery in high risk populations.
Technological improvements have contributed to market growth. Systems now incorporate automated feedback loops, improved sensors and wireless connectivity. Facilities in both mature and developing regions rely on temperature management devices to meet modern standards of care.
Overall, the market reflects a balance of strong clinical need, advances in non invasive platforms and evolving guidelines that shape long term strategies for post cardiac arrest cooling and perioperative warming.
Market Drivers
Demographic Factors
The global population over age 65 is increasing rapidly, driven by aging baby boomer groups and improved life expectancy. Older adults typically have higher rates of chronic conditions and are more likely to require complex medical interventions. As a result, they represent a growing proportion of patients requiring temperature management during surgery or after emergency events.
Healthcare utilization rises as populations age. More elderly individuals undergo cardiovascular procedures, orthopedic surgeries, neurosurgical procedures and emergency interventions. Temperature management is integrated into many of these care pathways, which increases demand for both surface and intravascular systems.
Interest in patient monitoring and homecare solutions is expanding as well. Patients and caregivers are more aware of the benefits of thermal regulation and how it contributes to safe recovery and improved outcomes. These demographic shifts contribute to the overall growth of the temperature management market.
Cardiovascular Disease Burden
Cardiovascular disease remains the leading cause of death worldwide. In 2021, it accounted for nearly one third of all deaths globally. Patients with CVD often require temperature management during cardiac procedures, after cardiac arrest and in related interventions.
Targeted temperature management is frequently used following out of hospital cardiac arrest. As the prevalence of CVD grows and more patients require emergency intervention, temperature management will continue to play a vital role in stabilizing patients and improving outcomes. This relationship between cardiovascular disease and TTM contributes significantly to market expansion.
Shift Toward Less Invasive Technology
Clinicians are moving toward less invasive platforms for temperature management. Surface pad systems provide effective thermal control without the risks associated with intravascular catheters. These systems require less training, reduce procedure time and are easier to manage in high acuity environments.
Surface pad systems are especially attractive after severe medical events such as cardiac arrest. They avoid complications related to invasive access, reduce infection risk and support broader deployment across facilities.
Advances in pad design, fluid circulation technology and intelligent temperature monitoring have increased the effectiveness of surface systems. As a result, clinicians view non invasive methods as safe and reliable alternatives to invasive techniques.
Market Limiters
Impact of European Guidelines
In 2022, the European Resuscitation Council and the European Society of Intensive Care Medicine revised their guidelines on post cardiac arrest care. New recommendations shifted focus away from therapeutic hypothermia and prioritized maintaining normothermia.
These changes were based on clinical trials that showed limited difference between targeted hypothermia and targeted normothermia in comatose out of hospital cardiac arrest patients. Because Europe represents a significant share of the global temperature management market, this shift has reduced growth potential in regions where cooling had been widely adopted.
As a result, global demand for temperature management devices is more limited than earlier forecasted projections suggested before guideline changes.
Lack of Clinical Data and Market Uncertainty
Targeted temperature management became common practice only in 2002. Since then, studies have raised questions about the benefits of deep cooling. As debate continues about the most effective approach, clinicians face uncertainty about long term best practices.
Some experts propose more high quality randomized trials to clarify the appropriate use of TTM after cardiac arrest. Until more clinical consensus is reached, adoption may be cautious in regions where protocols are being evaluated.
This uncertainty limits the long term growth potential of temperature management devices, especially in regions that follow evidence based guidelines closely.
Shift Toward Consignment Models
Temperature management machines are increasingly placed on consignment rather than purchased outright. Under these models, companies provide machines free of charge on the condition that hospitals purchase consumables such as catheters, pads and blankets on multi year contracts.
Consumables are lucrative for manufacturers and provide predictable revenue. However, because so many machines are installed free of charge, average selling prices for capital equipment are suppressed. This limits total market value even as unit placement grows.
Competition among vendors has intensified this trend. With limited capital purchasing funds available, vendors use consignment to secure long term relationships. While effective commercially, it depresses reported ASPs and restricts overall market growth in capital equipment.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Market forecasts
Growth rates
Units sold
Average selling prices
Qualitative Coverage
Growth trends
Market limiters
Competitive analysis and SWOT
Mergers and acquisitions
Company profiles and product portfolios
FDA recalls
Disruptive technologies
Disease and demographic overviews
Time Frame
Historical data from 2021 to 2024
Base year 2024
Forecasts to 2031
Data Sources
Primary interviews with industry leaders
Government physician and hospital datasets
Regulatory sources
Hospital private data
Import and export records
iData Research internal database
Markets Covered and Segmentation
Global Temperature Management Market Segmentation
Surface Pad Market
Further Segmented Into:
Machines
Accessories
Intravascular Market
Further Segmented Into:
Machines
Accessories
These segments include all capital systems, consumables, and related components used in temperature regulation across hospital departments.
Competitive Analysis
Becton Dickinson (BD)
BD was the leading competitor in the global temperature management market in 2024. Its flagship product line, Arctic Sun, is a non-invasive surface pad temperature management system that regulates patient temperature using circulating chilled water. The Arctic Sun 5000 system is the core of BD’s offering, providing advantages in performance, safety, cost effectiveness and ease of use.
In 2020, BD launched an upgraded technology known as the Arctic Sun Stat. This system offers improved ergonomics for enhanced usability, wireless connectivity for remote monitoring and control, and intelligent temperature fluctuation monitoring. BD also provides ArcticGel pads designed specifically for use with Arctic Sun systems.
ZOLL Medical
ZOLL Medical was the second leading competitor in 2024 due to its exclusive presence in the intravascular temperature management market. ZOLL offers the Thermogard XP system and the Thermogard HQ platform. The company also offers the STx Surface Cooling system, which it acquired from Philips following the acquisition of Philips’ InnerCool temperature management business in 2014.
ZOLL’s strong position in intravascular temperature management allows it to serve high acuity environments where precise control is required.
Gentherm
Gentherm held a notable share of the temperature management market in 2024. The company’s key products include the Blanketrol III hyper hypothermia system and the WarmAir convective warming system. Gentherm also offers accessories and consumables that support ongoing usage across a wide range of clinical settings.
Technology and Practice Trends
Temperature management technology continues to evolve across several dimensions:
Growth in non invasive systems as hospitals prioritize ease of use and reduced procedural risk
Improvements in fluid circulation systems that support faster warming or cooling
Wireless connectivity that allows clinicians to monitor and adjust temperatures remotely
Increased automation through intelligent feedback loops and advanced sensors
Expanded use of disposable pads and catheters to reduce infection risks
Integration of temperature management within perioperative and critical care protocols
These trends support wider adoption and improved clinical workflows.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where is the strongest growth potential within the temperature management market
How will evolving guidelines on therapeutic hypothermia influence purchasing
Which technologies are gaining traction across surface and intravascular platforms
What is the role of consumables in long term revenue generation
How do demographic and cardiovascular trends influence volume demand
Which competitors hold the strongest positions and why
How will consignment models shape future ASP trends
This report provides comprehensive insights for product planning, competitive positioning, commercial strategy and forecasting through 2031.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
56 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
